Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

June 3, 2020 updated by: AO Innovation Translation Center

A Prospective Multicenter Cohort Study to Evaluate the Benefit of the Geriatric Fracture Center (GFC) Concept

The study will assess patients with at least one major AE related to treatment / hospitalization / immobilization in the Geriatric Fracture Center (GFC) group compared to the usual care group.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients aged ≥ 70 years or older with an osteoporotic hip fracture treated with an osteosynthesis or endoprosthesis will be included in this study.

The primary objective of the study is to assess the difference in the numbers of pre-defined major adverse events (AE) which are related to the treatment, hospitalization and/or immobilization between patients who were treated in a geriatric fracture center or in a usual care center.

As a secondary objective, health economic implications and cost-effectiveness comparison analyses will be performed.

In order to be able to analyze data based on the geographic regions as well as globally, in each participating country, both a Geriatric Fracture Center (GFC) and a Usual Care Center (UCC) will be included.

Study Type

Observational

Enrollment (Actual)

282

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Innsbruck, Austria, 6020
        • Medical University of Innsbruck
      • Linz, Austria, 4020
        • AKH Linz
      • Almelo, Netherlands, 7609 SZ
        • Ziekenhuisgroep Twente
      • Maastricht, Netherlands, 6202 AZ
        • Maastricht University Medical Center
      • Singapore, Singapore, 308433
        • Tan Tock Seng Hospital
      • Singapore, Singapore, 169608
        • General Hospital Singapore
      • Marbella, Spain, 29603
        • Hospital Universitario Costa del Sol
    • Balearic Island
      • Palma de Mallorca, Balearic Island, Spain, 07198
        • Hospital Son Llatzer
      • Bangkok, Thailand, 10220
        • Bhumibol Adulyadej Hospital
      • Bangkok, Thailand, 10310
        • Hospital Medical Center Bangkok
    • Missouri
      • Saint Louis, Missouri, United States, 63104
        • Saint Louis University
    • New York
      • New York, New York, United States, 11373
        • Elmhurst Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Primary care clinic (Usual Care clinic) Geriatric center

Description

Preoperative Inclusion Criteria:

  • Age ≥ 70 years
  • Geriatric patients with hip fractures Treated either with oOsteosynthesis or oEndoprosthesis
  • Ability of the patient or assigned representative to understand the content of the patient information / Informed Consent Form
  • Signed and dated Institutional Review Board (IRB) / Ethics Committee (EC)-approved written informed consent

Preoperative Exclusion Criteria:

  • Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
GFC: Geriatric Fracture Center

Patient treatment in a geriatric fracture center

A GFC is defined as follows:

  • General geriatrician or ortho-geriatrician available in trauma/orthopaedic department
  • Geriatrician sees the patient prior to surgery (except if the patient is admitted over night or during weekends)
  • Local medical guidelines, consented by orthopedic surgeons and geriatrician
  • Pre-defined order set for assessing laboratory values
  • Pre-defined patient pathway to guarantee a fast track in the emergency room
  • Daily communication among involved specialists
  • Postoperative phase up to discharge from orthopaedic / trauma department (i.e. Discharge 1):

    • Daily patient visit by geriatrician
    • Daily patient visit by orthopedic surgeon in combination with nurse
    • Daily therapy by physiotherapists, except for weekends
    • Access to social workers, if required
UCC: Usual Care Center

Patient treatment in an usual care center

A UCC is defined as follows:

  • No geriatrician available in trauma/orthopaedic department
  • No pre-operative visit by a geriatrician as a standard
  • No pre-defined medical guidelines for geriatric fracture patients
  • Postoperative phase up to discharge from orthopaedic / trauma department (i.e. Discharge 1):

    • No daily patient visits by a geriatrician as a standard

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Major Adverse Events related to treatment / residential status / immobilization
Time Frame: From surgery up to 1 year follow-up

Major AEs related to treatment / residential status / immobilization:

  • Delirium
  • Congestive heart failure
  • Pneumonia
  • Deep venous thrombosis
  • Pulmonary embolism
  • Pressure ulcers
  • Myocardial infarction
From surgery up to 1 year follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Any other AEs not mentioned under primary outcome measure(s) as well as its relationship to the treatment / residential status / immobilization
Time Frame: From surgery up to 1 year follow-up
From surgery up to 1 year follow-up
Activities of daily living
Time Frame: Baseline, 12 weeks and 1 year postoperative
Modified Barthel index pre-injury, at 12 weeks and 12 months
Baseline, 12 weeks and 1 year postoperative
Number of re-admissions to an acute hospital
Time Frame: From surgery up to 1 year follow-up
From surgery up to 1 year follow-up
Timed up and go test (TUG)
Time Frame: 12 weeks and 1 year follow-up
12 weeks and 1 year follow-up
Parker Mobility Score
Time Frame: Baseline, 12 weeks and 1 year follow-up
Parker Mobility Score pre-injury, at 12 weeks and 12 months
Baseline, 12 weeks and 1 year follow-up
Mortality
Time Frame: From surgery up to 1 year follow-up
From surgery up to 1 year follow-up
Quality of Life
Time Frame: 12 weeks and 1 year postoperative
Quality of life using the EuroQoL questionnaire (EQ-5D)
12 weeks and 1 year postoperative
Pain
Time Frame: From surgery up to1 year follow-up
Pain using the numeric rating scale
From surgery up to1 year follow-up
Direct and indirect costs
Time Frame: Baseline up to 1 year follow-up
All direct and indirect costs will be documented for a cost-effectiveness analysis (medication, treatment, physiotherapy, postoperative care etc)
Baseline up to 1 year follow-up
Time from admission to start of pain medication
Time Frame: Baseline (admission to surgery), about 1-2 days
Baseline (admission to surgery), about 1-2 days
Time from admission to start of fluid management
Time Frame: Baseline (admission to surgery), about 1-2 days
Baseline (admission to surgery), about 1-2 days
Time from admission to surgery
Time Frame: Baseline (admission to surgery), about 1-2 days
Baseline (admission to surgery), about 1-2 days
Time from surgery to discharge 1 and 2
Time Frame: Baseline (admission to discharge), about 1-2 weeks
Discharge 1 is defined as discharge from orthopaedic / trauma department Discharge 2 is defined as the timepoint when the patient is discharged to their definite residential status, i.e. residential status where no further change in residential status is planned . Discharge 1 and 2 may occur on the same date.
Baseline (admission to discharge), about 1-2 weeks
Residential status
Time Frame: Baseline up to 1 year follow-up
Pre-injury, at discharge 1 and 2, at 12 weeks and 12 months
Baseline up to 1 year follow-up
Falls
Time Frame: From surgery up to 1 year follow-up
Numbers of falls
From surgery up to 1 year follow-up
Medication
Time Frame: Baseline up to 1 year follow-up
Number of different types of medication at admission, discharge 1, 12 weeks, 12 months and information whether analgesics, osteoporosis and other medications are administered at all study visit time points
Baseline up to 1 year follow-up
Number of patients receiving adequate secondary fracture prevention
Time Frame: Baseline up to 1 year follow-up
Baseline up to 1 year follow-up
Number of patients for which the nutrition status was evaluated / adapted
Time Frame: Baseline (admission to discharge), about 1-2 days
Baseline (admission to discharge), about 1-2 days
Occurrence of a contralateral hip fracture
Time Frame: Retrospective assessment of pre-injury status up to 1 year follow-up
Retrospective assessment of pre-injury status up to 1 year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Blauth, Professor, Medical University of Innsbruck

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

May 1, 2020

Study Registration Dates

First Submitted

November 17, 2014

First Submitted That Met QC Criteria

November 19, 2014

First Posted (Estimate)

November 21, 2014

Study Record Updates

Last Update Posted (Actual)

June 4, 2020

Last Update Submitted That Met QC Criteria

June 3, 2020

Last Verified

January 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Subscribe